Pedestrians walk past an electronic ticker board that indicates stock figures for Oil & Natural Gas Corp. (ONGC), from left, Reliance Industries Ltd., State Bank of India and Sun Pharmaceutical Industries Ltd. at the Bombay Stock Exchange (BSE) in Mumbai, India (Photographer: Dhiraj Singh/Bloomberg)

Stocks To Watch: Bandhan Bank, Cipla, IDFC Bank, Mindtree, NMDC

  • Punj Lloyd gets EPC order worth Rs 505.2 crore in Odisha from NHAI.
  • Wipro and Adobe expand partnership to offer enhanced digital services and solutions.
  • IDFC Bank-Capital First merger gets NSE approval.
  • Future Enterprises hikes stake in subsidiary Future E-commerce Infrastructure to 86.71 percent from 70.43 percent.
  • Cipla completes stake sale in UAE joint venture.
  • Bandhan Bank shares to start trading after IPO

Stocks in Asia followed their U.S. counterparts higher on signs that an escalation of trade tensions was beginning to ease.

The Singapore-traded SGX Nifty, an early indicator of NSE Nifty 50 Index’s performance in India, rose 0.2 percent at 10,174.50 as of 7:20 a.m.

Here Are The Stocks To Watch Out For In Tuesday’s Trade

  • PFC board approved Rs 57,000 crore market borrowing plan for the next financial year.
  • Punj Lloyd got EPC order worth Rs 505.2 crore in Odisha from NHAI.
  • Arihant Superstructures signed MOU with Maharashtra government to develop affordable housing project in Navi Mumbai.
  • Wipro and Adobe expand partnership to offer enhanced digital services and solutions.
  • NMDC to pay interim dividend of Rs 4.3 per share.
  • Dilip Buildcon declared L1 for four new HAM projects in Karnataka and Maharashtra worth Rs 4,114.5 crore.
  • KNR Constructions bagged two HAM projects worth Rs 2,964 crore from NHAI.
  • IDFC Bank–Capital First merger received NSE approval.
  • Mindtree launched “Decision Moments” platform to help markets drive faster conversions and increase customer lifetime value.
  • Brigade group unveiled Brigade Financial Centre at GIFT City.
  • Precision Camshafts to acquire 76 percent stake in Germany based MFT Motoren und Fahrzeugtechnik GmbH.
  • Future Enterprises hiked stake in subsidiary Future E-commerce Infrastructure to 86.71 percent from 70.43 percent.
  • Tata Metaliks said that the operations to be impacted due to shutdown of one of the blast furnaces at Kharagpur Plant.
  • Dolphin Offshore-consortium won order worth Rs 154 crore from ONGC.
  • Cipla completed stake sale in UAE joint venture.

New Offerings

  • Bandhan Bank to list on exchanges with a base price of Rs 375 per share. The issue was subscribed 14.6 times.
  • Lemon Tree Hotels IPO continues on day 2. The issue is subscribed 0.25 times
  • ICICI Securities fully subscribed after issue size cut to Rs 3,500 crore from Rs 4,000 crore earlier as retail and High Networth Investors stay away.

F&O Setup

  • Nifty March Futures closed trading at 10,146 premium 15.6 points versus 6 points.
  • Nifty April futures closed trading at 10,178 with a premium 47.7 points from 49.6 points.
  • All series: Nifty open interest down 2 percent, Bank Nifty open interest down 9 percent.
  • Rollover: Nifty 41 percent, Bank Nifty 24 percent.
  • India VIX ended at 15.1, down 2.2 percent.
  • Max open interest for March series at 10,500 call strike (open interest at 47.8 lakh, down 12 percent).
  • Max open interest for March series at 10,000 Put (open interest at 61.3 lakh, up 18 percent).

F&O Ban

  • In ban: IFCI, Jet Airways, JP Associates, Oriental Bank
  • New in ban: JP Associates
  • Out of ban: HDIL, IDBI Bank

Only intraday positions can be taken in stocks which are in F&O ban. There is a penalty in case of a rollover of these intraday positions.

Active Stock Futures

Stocks To Watch: Bandhan Bank, Cipla, IDFC Bank, Mindtree, NMDC

Bulk Deals

  • MT Educare: Kitara India Microreo Cap Growth Fund sold 3.70 lakh shares or 0.9 percent equity at Rs 70 each.
  • Shaily Engineering Plastics: HDFC MF bought 50,000 shares or 0.6 percent equity at Rs 1,150 each.
  • Venky’s: Dr Cyrus Poonawalla bought 83,186 shares or 0.6 percent equity at Rs 3916.60 each.

Acrysil

  • Ashish Kacholia bought 2.21 lakh shares or 4.3 percent equity at Rs 486 each.
  • Everest Finance & Investment Co sold 2.21 lakh shares or 4.3 percent equity at Rs 486 each.

Carborundum Universal

  • Reliance Small Cap Fund bought 20.20 lakh shares or 1.1 percent equity at Rs 337 each.
  • Promoter Ambadi Investments Ltd sold 25 lakh shares or 1.3 percent equity at Rs 337 each.

TCPL Packaging

  • Vijay Kedia sold 98,000 shares or 1.1 percent equity at Rs 600 each.
  • Vighnahar Holdings Pvt Ltd bought 98,000 shares or 1.1 percent equity at Rs 600 each.

TD Power Systems

  • MSD India Fund bought 8.56 lakh shares or 2.6 percent equity at Rs 185.06 each.
  • India Value Fund IV sold 7.55 lakh shares or 2.3 percent equity at Rs 185.14 each.

Elpro International

  • IGE (India) Pvt Ltd bought 15 lakh shares or 1.1 percent equity at Rs 47.5 each.
  • Elara India Opportunities Fund sold 11 lakh shares or 0.8 percent equity at Rs 47.5 each.

Transpek Industry

  • Hypnos Fund ltd bought 1.09 lakh shares or 2 percent equity at Rs 1,239.73 each.
  • Ruchit Patel sold 88,454 shares or 1.6 percent equity at Rs 1239.22 each.

T I Global

  • SMIFS Capital Marchkets bought 49,000 shares or 1 percent equity at Rs 68.5 each.
  • Maya Trade Links sold 49,559 shares or 1 percent equity at Rs 68.5 each.

International Conveyors

  • IGE (India) Pvt Ltd bought 13.89 lakh shares or 2.1 percent equity at Rs 21.5 each.
  • Elara India Opportunities Fund sold 11 lakh shares or 1.6 percent equity at Rs 21.5 each.

Brokerage Radar

Citi on Voltas

  • Maintained ‘Buy’ with a price target of Rs 744.
  • Indian AC market is at an inflection point.
  • Daikin is a formidable competitor for Voltas.
  • Daikin has set aggressive growth targets.
  • Daikin planning to set up third plant to grow.
  • Daikin has been a front-runner in R&D spending.
  • Voltas has successfully defended its turf in the past.
  • Voltas top India consumer electrical pick.

Citi on Cipla

  • Maintained ‘Buy’ with a price target of Rs 680.
  • Cipla launched an authorized generic version of Roche’s Aloxi.
  • Expect gAloxi to be 3-4 player market for six months.
  • Low gross margins but operating leverage upside.
  • FY19 could be a year of inflection in U.S. for Cipla.
  • Cipla continues to stand out among peers in difficult times.
  • Cipla continues to be top pick in the sector.

Morgan Stanley on Cadila

  • Maintained ‘Overweight’ with a price target of Rs 560.
  • Cadila announced USFDA approval of gToprol-XL; Market size of $700 million.
  • Product to help cushion gLialda/gTamilflu's upcoming normalization.
  • Expect more such launches over the next few quarters.
  • Launches to help re-rate the stock.

Jefferies on Syngene

  • Maintained ‘Buy’ with a price target of Rs 760.
  • Signs strategic deal with GSK.
  • Strong client addition provides growth visibility.
  • Pace of addition is a positive sign on earnings delivery.
  • Believe Syngene is best placed to gain market share.
  • Premium valuations to sustain given the structural growth drivers and strong execution.

Antique on NBCC (India)

  • Initiated ‘Buy’ with a price target of Rs 276; implying a potential upside of 45 percent from the last regular trade.
  • NBCC’s order backlog has swelled to an all-time high.
  • NBCC’s competitive edge is protected by legislations.
  • Expect compounded growth rate of 63 percent in revenue.
  • Revenue recognition is clustered around March 2020.
  • Current valuation attractive

INDSEC on Future Consumer

  • Initiated ‘Buy’ with a price target of Rs 69; implying a potential upside of 33 percent from the last regular trade.
  • Catering to changing consumption patterns through consumer centric approach.
  • Modern trade driven distribution network.
  • Diverse Product portfolio catering to niche segments.
  • Expect revenue to grow at a compounded rate of 42 percent over the fiscal 2017-2020.
  • Expect operating income to grow by 2.2 times between fiscal 2017-2020.
  • Expect loss in the current fiscal as well; Expect net profit in the next financial year.
  • Future Consumer could trade at better valuations going ahead.

Morgan Stanley on Banks

  • Borrowing calendar for the second half of the next fiscal has meaningful positive for PSU banks.
  • Borrowing budgeted is just 48 percent of annual budget.
  • Government intends to increase issuances in short and long-term maturity bucket.
  • Reduce medium-term issuance segment of 10-14 years to around 29 percent.
  • RBI and government in final stage of discussions for increasing FPI limit.
  • SBI preferred pick among PSU banks.

Trading Tweaks

  • East India Securities circuit filter revised to 20 percent.
  • GAIL India ex-date for 1:3 bonus issue. F&O lot size revised to 2,667.
  • Oil India ex-date for 1:2 bonus issue. F&O lot size revised to 3,399.
  • Kellton Tech Solutions ex-date for 1:1 bonus.
  • Talwalkars Better Value Fitness ex-date for demerger.

Who’s Meeting Whom

  • Purvankara to meet Fidelity Mgmt & Research on March 27.
  • Bodal Chemicals to meet Mahindra AMC on March 27.
  • PI Industries to meet Taiyo Pacific Partners and Narnolia Securities on March 27.
  • AIA Engineering to meet Edelweiss Securities on March 27.
  • Rallis India to meet Franklin Templeton MF on March 27.
  • Vakrangee to meet investors on March 27 and 28 in Singapore.
  • Magma Fincorp to meet several fund houses including Goldman Sachs, Samsung AMC, Marchshall Wace from March 27–29.
  • VRL Logistics to meet ICICI Prudential AMC on March 27.
  • Astra Poly Technik to meet ICICI Prudential MF and Emkay Global Financial Services on March 27.
  • TVS Motors to meet Goldman Sachs on March 28.
  • Pidilite to meet Axis Capital on March 28.

Insider Trades

  • Chambal Fertilizers promoter Mrs Nandini Nopany sold 2.75 lakh shares on March 23.
  • Cerebra Integrated Techologies promoters acquired 35,072 shares on March 23.
  • V2 retail promoter Vishal Waterworld acquired 80,207 shares from March 22–23.
  • Man Infra promoter Vatsal Shah acquired 68,500 shares on March 23.
  • Lasa Supergenerics promoter Svaks Biotech India Pvt Ltd sold 30,816 shares from March 19–20.